['anemia', 'non-dialysis dependent chronic kidney disease']
['vadadustat', 'placebo']

        Inclusion Criteria:

          -  Male and female Japanese subjects ≥20 years of age

          -  Diagnosis of CKD based on an estimated glomerular filtration rate ≤60 mL/min/1.73 m2

          -  Hb ≤10.5 g/dL

          -  Not currently being treated with dialysis and not expected to start dialysis within 3
             months of screening

        Exclusion Criteria:

          -  Anemia due to a cause other than CKD or presence of active bleeding or recent blood
             loss

          -  Sickle cell disease, myelodysplastic syndromes, bone marrow fibrosis, hematologic
             malignancy, myeloma, hemolytic anemia, thalassemia, or pure red cell aplasia

          -  Red blood cell transfusion within 4 weeks prior to or during screening

          -  Intravenous iron within 4 weeks prior to or during screening

          -  Any use of erythropoiesis-stimulating agents within 6 weeks prior to or during
             screening
      